Taekwang Industrial Q1 2026: Net Profit Despite Operating Loss, New Investments

Consolidated revenue KRW 533.3B (+5.1% YoY)
Consolidated operating loss KRW 11.4B (manufacturing segment loss)
Consolidated net profit KRW 28.4B (equity method gains from associates)
New acquisitions of Aekyung Industrial (31.56%) and Dongseong Pharmaceutical (31.05%) for ~KRW 252B
Increase in investment properties and PPE (construction in progress KRW 207.4B)
Debt ratio 13.5%, very stable financial structure (cash and equivalents KRW 452.6B)
Treasury stock 24.41% (potential shareholder return)
Major accident in Feb 2026 (chloroform exposure fatality), work suspension lifted in April
Some shareholder proposals (e.g., share buyback) rejected
Acrylic production ended (April 2026), LMF production halted previously